Speakers

Christof Bull
Christof Bull
Christof Bull is a European Patent Attorney and Associate General Patent Counsel for UCB, a global biopharmaceutical company headquartered in Brussels, Belgium. Christof currently works for UCB’s China affiliate in Shanghai.
Christof has been working as in-house patent counsel for several biopharma companies for more than 17 years. He joined UCB in 2008. Prior to UCB, he worked for Merck Serono, Serono in Geneva, Switzerland and for Bayer AG in Leverkusen, Germany. He heads up a team of biotech patent attorneys supporting globally UCB’s biotechnology products as well as biotech manufacturing activities with respect to all IP matters. Christof works on all key aspects of intellectual property, including prosecution and litigation. During many years as in-house patent counsel, Christof has been involved in numerous negotiations related to transactions and handled IP due diligences, including with respect to monoclonal antibody products, as well as technologies for antibody discovery and biotech manufacturing.
Christof, who is a German national, studied biochemistry in Berlin, Germany and received his Ph.D. in molecular immunology from the Freie Universität Berlin in 1999. He has subsequently worked in human genetics as a post-doctoral scientist at the Max-Planck-Institute for Molecular Genetics.
UCB (www.ucb.com) has a strong footprint in epilepsy and other CNS diseases as well as autoimmune diseases. Through the acquisition of the British biotech pioneer Celltech in 2004, UCB acquired cutting-edge antibody discovery capabilities and a strong biotech pipeline with the anti-TNF Cimzia® which was launched in 2008 as UCB’s first innovative biotech product. UCB has various antibody products in different stages of clinical development.
  
  

  Media Partner